Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Alexandria Real Estate Equities (ARE)

Alexandria Real Estate Equities adds Claire Aldridge to board, expanding it to nine directors

Neutral Impact 2 of 5 leadership Written later

Alexandria Real Estate Equities elected Claire Aldridge, PhD, as a director effective March 14, 2025, increasing the board from eight to nine members. She was also appointed to the Life Science Committee and was determined to be independent under NYSE and SEC rules.

Key points

  • Board elected Dr. Claire Aldridge as a director on February 28, 2025, effective March 14, 2025; term runs until the 2025 annual meeting
  • Board size increased from eight to nine directors; Dr. Aldridge joins the Life Science Committee
  • Dr. Aldridge receives 1,000 shares of restricted stock that vest in full on the second anniversary of the grant date
  • Previously Chief Strategy Officer of Form Bio from July 2022 to August 2024

The filing

CompanyAlexandria Real Estate Equities (ARE)
Form8-K, current report
Filed with the SECMar 6, 2025, 4:20 PM ET
Accession number0001104659-25-021383

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.